← Open Payments lookup

AMY AUGUSTINE: Open Payments

NPI 1508690827 · DUNDALK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,857 in 148 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $378 · 2025 $2,857

Food & beverage: $2,857
CompanyPaymentsAmount
Novo Nordisk Inc19$317
PFIZER INC.15$247
ABBVIE INC.20$243
Bayer Healthcare Pharmaceuticals Inc.9$210
AstraZeneca Pharmaceuticals LP8$207
Vanda Pharmaceuticals Inc.7$183
Indivior Inc.8$174
Lilly USA, LLC6$142
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$120
Boehringer Ingelheim Pharmaceuticals, Inc.5$109

Products named: Kerendia, HETLIOZ, SUBLOCADE, Ozempic, BREZTRI, MOUNJARO, VRAYLAR, ELIQUIS.

Industry payments across MD — which companies pay providers there.